The Hard Reality of Frontotemporal Dementia: Beyond the Research Hype

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T ...

BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma ...